However, in recent years, the clinical genetic testing approach for hereditary breast cancer has shifted from single to multigene panel testing, resulting in the increased identification of patients with pathogenic variants in predisposition genes beyond BRCA1/2 (7-9). Here, BRCA1 is linked to breast carcinoma.